Specific molecular mutation patterns delineate chronic neutrophilic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia.
作者信息
Meggendorfer Manja, Haferlach Torsten, Alpermann Tamara, Jeromin Sabine, Haferlach Claudia, Kern Wolfgang, Schnittger Susanne
机构信息
MLL Munich Leukemia Laboratory, Germany
MLL Munich Leukemia Laboratory, Germany.
出版信息
Haematologica. 2014 Dec;99(12):e244-6. doi: 10.3324/haematol.2014.113159. Epub 2014 Sep 19.
Abstract
摘要
相似文献
1
Specific molecular mutation patterns delineate chronic neutrophilic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia.特定的分子突变模式可区分慢性嗜中性粒细胞白血病、非典型慢性髓性白血病和慢性粒单核细胞白血病。
Haematologica. 2014 Dec;99(12):e244-6. doi: 10.3324/haematol.2014.113159. Epub 2014 Sep 19.
2
Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia.慢性中性粒细胞白血病、慢性粒单核细胞白血病及非典型慢性髓系白血病的分子遗传学
J Hematol Oncol. 2014 Dec 12;7:93. doi: 10.1186/s13045-014-0093-1.
3
The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment.慢性中性粒细胞白血病和非典型 CML 的新遗传学：对诊断和治疗的影响。
Blood. 2013 Sep 5;122(10):1707-11. doi: 10.1182/blood-2013-05-500959. Epub 2013 Jul 29.
4
CSF3R-mutant chronic myelomonocytic leukemia is a distinct clinically subset with abysmal prognosis: a case report and systematic review of the literature.CSF3R 突变型慢性粒单核细胞白血病是一种具有极差预后的独特临床亚型：病例报告及文献系统回顾。
Leuk Lymphoma. 2023 Sep;64(9):1566-1573. doi: 10.1080/10428194.2023.2227750. Epub 2023 Jul 3.
5
CSF3R mutated myeloid neoplasms: Beyond chronic neutrophilic leukemia.CSF3R 突变型髓系肿瘤：超越慢性中性粒细胞白血病。
Hum Pathol. 2024 Jul;149:66-74. doi: 10.1016/j.humpath.2024.06.008. Epub 2024 Jun 13.
6
Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management.慢性中性粒细胞白血病和不典型慢性髓性白血病：2024 年诊断、遗传学、风险分层和治疗更新。
Am J Hematol. 2024 Jul;99(7):1360-1387. doi: 10.1002/ajh.27321. Epub 2024 Apr 21.
7
What's different about atypical CML and chronic neutrophilic leukemia?非典型慢性髓性白血病和慢性嗜中性粒细胞白血病有何不同？
Hematology Am Soc Hematol Educ Program. 2015;2015:264-71. doi: 10.1182/asheducation-2015.1.264.
8
[Molecular characterization of atypical chronic myeloid leukemia and chronic neutrophilic leukemia].[非典型慢性髓系白血病和慢性嗜中性粒细胞白血病的分子特征]
Med Clin (Barc). 2015 Jun 8;144(11):487-90. doi: 10.1016/j.medcli.2014.03.020. Epub 2014 May 20.
9
Analysis of CSF3R mutations in atypical chronic myeloid leukemia and other myeloid malignancies.分析非典型慢性髓性白血病和其他髓系恶性肿瘤中的 CSF3R 突变。
Ann Diagn Pathol. 2024 Aug;71:152317. doi: 10.1016/j.anndiagpath.2024.152317. Epub 2024 Apr 18.
10
T618I-Mutated Colony Stimulating Factor 3 Receptor in Chronic Neutrophilic Leukemia and Chronic Myelomonocytic Leukemia Patients who Underwent Allogeneic Stem Cell Transplantation.接受异基因干细胞移植的慢性中性粒细胞白血病和慢性粒单核细胞白血病患者中的T618I突变型集落刺激因子3受体
Ann Lab Med. 2015 May;35(3):376-8. doi: 10.3343/alm.2015.35.3.376. Epub 2015 Apr 1.
引用本文的文献
1
Expanding the Spectrum of -Mutated Myeloid Neoplasm Beyond Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia: A Comprehensive Analysis of 13 Cases.将-mutated髓系肿瘤的谱系扩展至慢性中性粒细胞白血病和非典型慢性髓系白血病之外：13例病例的综合分析
J Clin Med. 2025 Jul 22;14(15):5174. doi: 10.3390/jcm14155174.
2
Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia.360例髓系肿瘤中不同类型CSF3R突变的分布及共突变模式
Ann Hematol. 2025 Jan;104(1):263-274. doi: 10.1007/s00277-025-06232-1. Epub 2025 Feb 5.
3
Chronic Neutrophilic Leukemia: Advances in Diagnosis, Genetic Insights, and Management Strategies.慢性中性粒细胞白血病：诊断、遗传学见解及管理策略的进展
Cancers (Basel). 2025 Jan 12;17(2):227. doi: 10.3390/cancers17020227.
4
Dual ASXL1 and CSF3R mutations drive myeloid-biased stem cell expansion and enhance neutrophil differentiation.ASXL1和CSF3R双突变驱动髓系偏向性干细胞扩增并增强中性粒细胞分化。
Blood Adv. 2025 Apr 8;9(7):1593-1607. doi: 10.1182/bloodadvances.2024014362.
5
Genomic Landscape of Myelodysplastic/Myeloproliferative Neoplasms: A Multi-Central Study.骨髓增生异常/骨髓增殖性肿瘤的基因组景观：一项多中心研究。
Int J Mol Sci. 2024 Sep 23;25(18):10214. doi: 10.3390/ijms251810214.
6
Case report: Safety and efficacy of synergistic treatment using selinexor and azacitidine in patients with atypical chronic myeloid leukemia with resistance to decitabine.病例报告：塞利尼索与阿扎胞苷联合治疗对地西他滨耐药的非典型慢性髓性白血病患者的安全性和有效性
Front Oncol. 2024 Feb 7;14:1353818. doi: 10.3389/fonc.2024.1353818. eCollection 2024.
7
Research progress of additional pathogenic mutations in chronic neutrophilic leukemia.慢性中性粒细胞白血病中附加致病性突变的研究进展。
Ann Hematol. 2024 Aug;103(8):2591-2600. doi: 10.1007/s00277-023-05550-6. Epub 2023 Nov 22.
8
Characteristics, primary treatment, and survival of MDS/MPN with neutrophilia: a population-based study.伴有中性粒细胞增多的 MDS/MPN 的特征、主要治疗方法和生存情况：一项基于人群的研究。
Blood Adv. 2023 Dec 26;7(24):7554-7563. doi: 10.1182/bloodadvances.2023011181.
9
Differential diagnoses and the mutational landscape of myelodysplastic/myeloproliferative neoplasm with neutrophilia: A case report.伴嗜中性粒细胞增多的骨髓增生异常/骨髓增殖性肿瘤的鉴别诊断及突变图谱：一例报告
Mol Clin Oncol. 2023 Jun 28;19(2):62. doi: 10.3892/mco.2023.2658. eCollection 2023 Aug.
10
Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Differential Diagnosis in the WHO and ICC 2022 Era: A Focused Review.2022年世界卫生组织（WHO）和国际癌症研究机构（ICC）时代的骨髓增生异常综合征/骨髓增殖性重叠肿瘤及其鉴别诊断：重点综述
Cancers (Basel). 2023 Jun 13;15(12):3175. doi: 10.3390/cancers15123175.
本文引用的文献
1
The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment.慢性中性粒细胞白血病和非典型 CML 的新遗传学：对诊断和治疗的影响。
Blood. 2013 Sep 5;122(10):1707-11. doi: 10.1182/blood-2013-05-500959. Epub 2013 Jul 29.
2
Prognostic score including gene mutations in chronic myelomonocytic leukemia.包含基因突变的慢性髓单核细胞白血病预后评分。
J Clin Oncol. 2013 Jul 1;31(19):2428-36. doi: 10.1200/JCO.2012.47.3314. Epub 2013 May 20.
3
Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.致癌性 CSF3R 突变在慢性中性粒细胞白血病和非典型 CML 中的作用。
N Engl J Med. 2013 May 9;368(19):1781-90. doi: 10.1056/NEJMoa1214514.
4
SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations.SETBP1 突变发生在 9%的 MDS/MPN 和 4%的 MPN 病例中，与非典型 CML、单体 7、i(17)(q10) 等臂染色体、ASXL1 和 CBL 突变密切相关。
Leukemia. 2013 Sep;27(9):1852-60. doi: 10.1038/leu.2013.133. Epub 2013 Apr 30.
5
Mutations and prognosis in primary myelofibrosis.原发性骨髓纤维化中的突变与预后。
Leukemia. 2013 Sep;27(9):1861-9. doi: 10.1038/leu.2013.119. Epub 2013 Apr 26.
6
CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.CSF3R T618I 是慢性中性粒细胞白血病中一种高度普遍且特异性的突变。
Leukemia. 2013 Sep;27(9):1870-3. doi: 10.1038/leu.2013.122. Epub 2013 Apr 22.
7
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia.非典型慢性髓性白血病中反复出现的 SETBP1 突变。
Nat Genet. 2013 Jan;45(1):18-24. doi: 10.1038/ng.2495. Epub 2012 Dec 9.
8
SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML).275 例慢性粒单核细胞白血病（CMML）患者中的 SRSF2 突变。
Blood. 2012 Oct 11;120(15):3080-8. doi: 10.1182/blood-2012-01-404863. Epub 2012 Aug 23.
9
Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases.ASXL1 基因突变与恶性髓系疾病谱中的不良预后相关。
J Hematol Oncol. 2012 Mar 21;5:12. doi: 10.1186/1756-8722-5-12.
10
Frequent pathway mutations of splicing machinery in myelodysplasia.骨髓增生异常综合征中剪接机制的频繁通路突变。
Nature. 2011 Sep 11;478(7367):64-9. doi: 10.1038/nature10496.
Zotero 插件